Association of diabetes with mammographic breast density and breast cancer in the Minnesota breast cancer family study

Cancer Causes and Control

Volumn 18, Issue 5, 2007, Pages 505-515

  Sellers, Thomas A ^a   Jensen, Leif E ^b   Vierkant, Robert A ^b   Fredericksen, Zachary S ^b   Brandt, Kathleen R ^b   Giuliano, Anna R ^a   Pankratz, Vernon S ^b   Cerhan, James R ^b   Vachon, Celine M ^b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b Mayo Clinic   (United States)

Author keywords

Cohort; Menopause; Risk factor

Indexed keywords

ADULT; ARTICLE; BREAST; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; COVARIANCE; DENSITY; DIABETIC PATIENT; DISEASE ASSOCIATION; FAMILY STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MENOPAUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SELF REPORT; STATISTICAL SIGNIFICANCE;

BREAST NEOPLASMS; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MAMMOGRAPHY; MINNESOTA; RISK FACTORS;

EID: 34247627353     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-007-0128-9     Document Type: Article

References (52)

1. Michels KB, Solomon CG, Hu FB, Rosner BA, Hankinson SE, Colditz G et al (2003) Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study. Diabetes Care 26:1752-1758
2. Adami HO, McLaughlin J, Ekbom A, Berne C, Silverman D, Hacker D et al (1991) Cancer risk in patients with diabetes mellitus. Cancer Causes Control 2:307-314
3. Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ (2004) Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 159:1160-1167
4. Franceschi S, la Vecchia C, Negri E, Parazzini F, Boyle P (1990) Breast cancer risk and history of selected medical conditions linked with female hormones. Eur J Cancer 26:781-785
5. Baron JA, Weiderpass E, Newcomb PA, Stampfer M, Titus-Ernstoff L, Egan KM et al (2001) Metabolic disorders and breast cancer risk (United States). Cancer Causes Control 12:875-880
6. Mink PJ, Shahar E, Rosamond WD, Alberg AJ, Folsom AR (2002) Serum insulin and glucose levels and breast cancer incidence: the atherosclerosis risk in communities study. Am J Epidemiol 156:349-352
7. O'Mara BA, Byers T, Schoenfeld E (1985) Diabetes mellitus and cancer risk: a multisite case-control study. J Chronic Dis 38:435-441
8. Ragozzino M, Melton LJ, Chu CP, Palumbo PJ (1982) Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J Chronic Dis 35:13-19
9. Talamini R, Franceschi S, Favero A, Negri E, Parazzini F, La Vecchia C (1997) Selected medical conditions and risk of breast cancer. Br J Cancer 75:1699-1703
10. Sellers TA, Sprafka JM, Gapstur SM, Rich SS, Potter JD, Ross JA, McGovern PG et al (1994) Does body fat distribution promote familial aggregation of adult onset diabetes mellitus and postmenopausal breast cancer? Epidemiology 5:102-108
11. Wolf I, Sadetzki S, Catane R, Karasik A, Kaufman B (2005) Diabetes mellitus and breast cancer. Lancet Oncol 6:103-111
12. Strickler HD, Wylie-Rosett J, Rohan T, Hoover DR, Smoller S, Burk RD et al (2001) The relation of type 2 diabetes and cancer. Diabetes Technol Ther 3:263-274
13. Sugumar A, Liu YC, Xia Q, Koh YS, Matsuo K (2004) Insulin-like growth factor (IGF)-I and IGF-binding protein 3 and the risk of premenopausal breast cancer: a meta-analysis of literature. Int J Cancer 111:293-297
14. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M (2004) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363:1346-1353
15. Fletcher O, Gibson L, Johnson N, Altmann DR, Holly JM, Ashworth A, Peto J, Silva Idos S (2005) Polymorphisms and circulating levels in the insulin-like growth factor system and risk of breast cancer: a systematic review. Cancer Epidemiol Biomarkers Prev 14:2-19
16. Li BD, Khosravi MJ, Berkel HJ, Diamandi A, Dayton MA, Smith M et al (2001) Free insulin-like growth factor-I and breast cancer risk. Int J Cancer 91:736-739
17. Toniolo P, Bruning PF, Akhmedkhanov A, Bonfrer JM, Koenig KL, Lukanova A et al (2000) Serum insulin-like growth factor-I and breast cancer. Int J Cancer 88:828-832
18. Krajcik RA, Borofsky ND, Massardo S, Orentreich N (2002) Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer. Cancer Epidemiol Biomarkers Prev 11:1566-1573
19. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B et al (1998) Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351:1393-1396
20. Schernhammer ES, Holly JM, Pollak MN, Hankinson SE (2005) Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 14:699-704
21. Malin A, Dai Q, Yu H, Shu XO, Jin F, Gao YT et al (2004) Evaluation of the synergistic effect of insulin resistance and insulin-like growth factors on the risk of breast carcinoma. Cancer 100:694-700
22. Rinaldi S, Peeters PH, Berrino F, Dossus L, Biessy C, Olsen A et al (2006) IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer 13:593-605
23. Schernhammer ES, Holly JM, Hunter DJ, Pollak MN, Hankinson SE (2006) Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II. Endocr Relat Cancer 13:583-592
24. Renehan AG, Harvie M, Howell A (2006) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and breast cancer risk: eight years on. Endocr Relat Cancer 13:273-278
25. Boyd NF, Lockwood GA, Byng JW, Tritchler DL, Yaffe MJ (1998) Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev 7:1133-1144
26. Whitehead J, Carlile T, Kopecky KJ, Thompson DJ, Gilbert FI, Present AJ et al (1985) The relationship between Wolfe's classification of mammograms, accepted breast cancer risk factors, and the incidence of breast cancer. Am J Epidemiol 122:994-1006
27. Bartow SA, Pathak DR, Mettler FA, Key CR, Pike MC (1995) Breast mammographic pattern: a concatenation of confounding and breast cancer risk factors. Am J Epidemiol 142:813-819
28. Vachon CM, Kuni CC, Anderson K, Anderson VE, Sellers TA (2000) Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). Cancer Causes Control, 11:653-662
29. Maskarinec G, Williams AE, Kaaks R (2003) A cross-sectional investigation of breast density and insulin-like growth factor I. Int J Cancer 107:991-996
30. Byrne C, Colditz GA, Willett WC, Speizer FE, Pollak M, Hankinson SE (2000) Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density. Cancer Res 60:3744-3748
31. Boyd NF, Dite GS, Stone J, Gunasekara A, English DR, McCredie MR et al (2002) Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med 347:886-894
32. Berube S, Diorio C, Verhoek-Oftedahl W, Brisson J (2004) Vitamin D, calcium, and mammographic breast densities. Cancer Epidemiol Biomarkers Prev 13:1466-1472
33. Diorio C, Pollak M, Byrne C, Masse B, Hebert-Croteau N, Yaffe M et al (2005) Insulin-like growth factor-I, IGF-binding protein-3, and mammographic breast density. Cancer Epidemiol Biomarkers Prev 14:1065-1073
34. Guo YP, Martin LJ, Hanna W, Banerjee D, Miller N, Fishell E et al (2001) Growth factors and stromal matrix proteins associated with mammographic densities. Cancer Epidemiol Biomarkers Prev 10:243-248
35. Roubidoux MA, Kaur JS, Griffith KA, Sloan J, Wilson C, Novotny P et al (2003) Correlates of mammogram density in southwestern Native-American women. Cancer Epidemiol Biomarkers Prev 12:552-558
36. Sellers TA, Anderson VE, Potter JD, Bartow SA, Chen PL, Everson L et al (1995) Epidemiologic and genetic follow-up study of 544 Minnesota breast cancer families: design and methods. Genetic Epidemiol 12:417-429
37. Sellers TA, King RA, Cerhan JR, Chen PL, Grabrick DM, Kushi LH et al (1999) Fifty-year follow-up of cancer incidence in a historical cohort of Minnesota breast cancer families. Cancer Epidemiol Biomarkers Prev 8:1051-1057
38. Weaver TW, Kushi LH, McGovern PG, Potter JD, Rich SS, King RA et al (1996) Validation study of self-reported measures of fat distribution. Int J Obes Relat Metab Disord 20:644-650
39. Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ (1994) The quantitative analysis of mammographic densities. Phys Med Biol 39:1629-1638
40. Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ (1996) Automated analysis of mammographic densities. Phys Med Biol 41:909-923
41. Hjalgrim H, Frisch M, Ekbom A, Kyvik KO, Melbye M, Green A (1997) Cancer and diabetes - a follow-up study of two population-based cohorts of diabetic patients. J Intern Med 241:471-475
42. Grabrick DM, Hartmann LC, Cerhan JR, Vierkant RA, Therneau TM, Vachon CM et al (2000) Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer. JAMA 284:1791-1798
43. Korn EL, Graubard BI, Midthune D (1997) Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol 145:72-80
44. Fisher LD, Lin DY (1999) Time-dependent covariates in the Cox proportional-hazards regression model. Annu Rev Public Health 20:145-157
45. Therneau TM, Grambsch PM (2000) Modeling survival data: extending the Cox model. Statistics for biology and health. Springer, New York
46. Strange KS, Wilkinson D, Edin G, Emerman JT (2004) Mitogenic properties of insulin-like growth factors I and II, insulin-like growth factor binding protein-3 and epidermal growth factor on human breast stromal cells in primary culture. Breast Cancer Res Treat 84:77-84
47. Strange KS, Wilkinson D, Emerman JT (2002) Mitogenic properties of insulin-like growth factors I and II, insulin-like growth factor binding protein-3 and epidermal growth factor on human breast epithelial cells in primary culture. Breast Cancer Res Treat 75:203-212
48. Sandhu MS (2005) Insulin-like growth factor-I and risk of type 2 diabetes and coronary heart disease: molecular epidemiology. Endocr Dev 9:44-54
49. Dunger DB, Ong KK, Sandhu M (2003) Serum insulin-like growth factor-I levels and potential risk of type 2 diabetes. Horm Res 60(Suppl 3):131-135
50. Frystyk J, Skjaerbaek C, Vestbo E, Fisker S, Orskov H (1999) Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes. Diabetes Metab Res Rev 15:314-322
51. Eliassen AH, Colditz GA, Rosner B, Willett WC, Hankinson SE (2006) Adult weight change and risk of postmenopausal breast cancer. JAMA 296:193-201
52. Harvie M, Howell A, Vierkant RA, Kumar N, Cerhan JR, Kelemen LE et al (2005) Association of gain and loss of weight before and after menopause with risk of postmenopausal breast cancer in the Iowa women's health study. Cancer Epidemiol Biomarkers Prev 14:656-661